Cortical Changes After Upper Limb Immobilization Measured by Electroencephalography (EEG)

June 2, 2026 updated by: Atenea Villalobos-García, University of Malaga

Effects of Upper Limb Immobilization on Sensorimotor Cortical Activity and Function Measured by EEG: A Prospective Observational Study

This study aims to investigate how temporary immobilization of the upper limb after injury affects brain activity and functional recovery.

Participants with fractures or soft tissue injuries of the upper limb who require immobilization will be evaluated at three time points: at the beginning of immobilization, after removal of the immobilization, and four weeks later.

Brain activity will be measured using electroencephalography (EEG), a non-invasive and painless technique that records electrical signals from the scalp. Functional outcomes such as pain, mobility, strength, and daily activity performance will also be assessed using validated questionnaires and clinical tests.

The purpose of this study is to better understand how immobilization influences the brain and physical recovery, in order to improve rehabilitation strategies for patients with upper limb injuries.

Participation is voluntary, and all participants will provide written informed consent.

Study Overview

Detailed Description

Upper limb immobilization is commonly required after fractures and soft tissue injuries to promote healing. However, prolonged immobilization can lead to muscle weakness, sensory deficits, and changes in brain activity related to motor control.

Previous research has shown that even short periods of limb disuse can induce neuroplastic changes in the sensorimotor cortex. These changes may contribute to persistent functional limitations after immobilization is removed.

This prospective observational study aims to describe and quantify changes in sensorimotor cortical activity and functional outcomes associated with clinical immobilization of the upper limb.

Adult patients requiring immobilization for upper limb fractures or soft tissue injuries will be recruited. Eligible participants will be evaluated at three time points: baseline (within five days of immobilization), post-immobilization (within 24-48 hours after removal), and follow-up (four weeks after post-immobilization).

Brain activity will be recorded using a portable wireless electroencephalography (EEG) system following the international 10-20 electrode placement system. Resting-state and task-related recordings will be obtained. Spectral power in standard frequency bands and functional connectivity measures will be analyzed.

Clinical and functional outcomes will include patient-reported questionnaires (PRWE, QuickDASH, MHQ, SPADI, TSK-11, PCS), range of motion, grip strength, and joint position sense.

Statistical analyses will focus on longitudinal changes across time points using repeated-measures analysis of variance or mixed-effects models, depending on data distribution. Effect sizes and confidence intervals will be reported.

This study has been approved by the local ethics committee, and all participants will provide written informed consent prior to participation.

The results are expected to contribute to a better understanding of brain plasticity during immobilization and support the development of more effective rehabilitation strategies.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Málaga
      • Málaga, Málaga, Spain, 29071
        • UMA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients requiring orthopedic immobilization of the upper limb following fracture or soft tissue injury. Participants are consecutively referred from the traumatology units of hospitals in Málaga and undergo clinical and neurophysiological evaluation under supervision of the research team. The study population represents individuals undergoing routine clinical immobilization and subsequent rehabilitation as part of standard orthopedic management.

Description

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Radiologically confirmed upper limb fracture (distal radius, proximal humerus, metacarpals, phalanges, or carpal bones) or soft tissue injury (e.g., tendinopathy, triangular fibrocartilage complex injury).
  • Requirement of orthopedic immobilization of the wrist/hand extending to the proximal two-thirds of the forearm for a minimum of 2 weeks and a maximum of 8 weeks.
  • Ability to understand study procedures and follow instructions.
  • Provision of written informed consent.

Exclusion Criteria:

  • History of neurological disorders (e.g., stroke, epilepsy, traumatic brain injury).
  • Current use of psychoactive or anticonvulsant medication.
  • Bilateral upper limb injuries.
  • Wrist fractures requiring elbow immobilization.
  • Previous upper limb fracture or instability within the last 2 years.
  • Cognitive impairment preventing adequate participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Upper Limb Immobilization Cohort
Adults with upper limb fracture or soft tissue injury requiring orthopedic immobilization for 2-8 weeks. Participants undergo repeated neurophysiological and clinical assessments at baseline (within 5 days from the start of immobilization), post-immobilization (within 24-48 hours after removal of the immobilization), and 4-week follow-up (4 weeks after splint or cast removal).
Standard orthopedic immobilization of the upper limb (wrist/hand) as part of routine clinical management following fracture or soft tissue injury.
Conventional wrist and hand rehabilitation provided according to clinical practice after immobilization removal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Sensorimotor Cortical Activity Measured by EEG
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Changes in sensorimotor cortical activity measured using electroencephalography (EEG), including spectral power in mu (8-13 Hz) and beta (13-30 Hz) frequency bands over central regions (C3, C4 and adjacent electrodes), and functional connectivity between motor and somatosensory areas.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Upper Limb Pain and Disability (PRWE)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Patient-Rated Wrist Evaluation (PRWE) total score (0-100), assessing pain and functional disability of the wrist and hand. Higher scores indicate greater pain and disability.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Upper Limb Functional Status (QuickDASH)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH), 11-item self-reported measure of upper limb disability (0-100). Higher scores indicate greater disability.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Hand Function (Michigan Hand Outcomes Questionnaire)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Michigan Hand Outcomes Questionnaire (MHQ) total score assessing hand function, activities of daily living, pain, work performance, aesthetics, and satisfaction. Scores range from 0 to 100 depending on domain.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Shoulder Pain and Disability (SPADI)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Shoulder Pain and Disability Index (SPADI), 13-item questionnaire assessing shoulder pain and disability. Scores range from 0 to 100, with higher scores indicating greater impairment.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Grip Strength
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Grip strength measured in kilograms using a Jamar dynamometer under standardized positioning (shoulder adducted, elbow flexed 90°, forearm neutral). Bilateral measurements recorded.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Wrist Range of Motion
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Active wrist range of motion (flexion, extension) measured in degrees using a goniometer under standardized positioning.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Joint Position Sense (Proprioception)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Joint Position Sense (JPS) error measured in degrees as the absolute difference between target and reproduced wrist position.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Pain Catastrophizing (PCS)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Pain Catastrophizing Scale (PCS), a 13-item self-reported questionnaire assessing rumination, magnification, and helplessness related to pain. Each item is scored from 0 to 4. Total scores range from 0 to 52, with higher scores indicating greater pain catastrophizing.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Change in Kinesiophobia (TSK-11)
Time Frame: Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.
Tampa Scale for Kinesiophobia (TSK-11), an 11-item self-reported questionnaire measuring fear of movement and reinjury. Each item is rated on a 4-point Likert scale. Total scores range from 11 to 44, with higher scores indicating greater fear of movement.
Baseline (within 5 days of immobilization), 24-48 hours after immobilization removal, and 4 weeks post-removal.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

February 16, 2026

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 23, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 2, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UMA-EEG-IMM-2026-002
  • 231-2025-H (Registry Identifier: CEUMA)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muskuloskeletal Diseases

Clinical Trials on Orthopedic Immobilization

Subscribe